What does everyone think of this latest research report? It offers more in terms of financials than the previous report. I'm wondering about a couple of things. The revenue forecasted for FY18 is $5,331,357, but Orthocell's revenue in the report for the half year ended 31 December 2017 was $488,575. Does this mean that for the half year ending 30 June 2018, revenue will be $4,842,782? How could this be possible? Has the CelGro device for the suture-less repair of soft tissue caused a sudden jump in sales?
Also in regards to the DCF methodology used to value the company, Cedrus have said that they expect the share price to be $1.66 by end of FY19. This would coincide with the regulatory approval of CelGro - the report states: "Currently the company is marketing the CelGro® platform for dental implantation applications in Europe, and is preparing for commercialization in the U.S. and Australia in FY2019 ending on 30 June 2019."
This would suggest that CelGro still has a way to go so will not be a major revenue generator in 2018 - where is the majority of Orthocell's revenue coming from at the moment? Is the forecasted revenue for FY18 and the price target of $1.66 by end of FY19 realistic?
- Forums
- ASX - By Stock
- Ann: Cedrus Investments Initiation of Coverage
What does everyone think of this latest research report? It...
-
- There are more pages in this discussion • 7 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add OCC (ASX) to my watchlist
(20min delay)
|
|||||
Last
45.0¢ |
Change
-0.015(3.23%) |
Mkt cap ! $94.30M |
Open | High | Low | Value | Volume |
47.0¢ | 47.0¢ | 44.8¢ | $101.0K | 221.6K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 6739 | 44.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
45.0¢ | 9799 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 4539 | 0.445 |
3 | 82109 | 0.440 |
2 | 19005 | 0.430 |
1 | 40000 | 0.425 |
3 | 18904 | 0.420 |
Price($) | Vol. | No. |
---|---|---|
0.450 | 9799 | 1 |
0.455 | 30999 | 1 |
0.465 | 7230 | 2 |
0.470 | 59673 | 2 |
0.475 | 20000 | 1 |
Last trade - 16.10pm 13/09/2024 (20 minute delay) ? |
Featured News
OCC (ASX) Chart |
The Watchlist
LPM
LITHIUM PLUS MINERALS LTD.
Simon Kidston, Non--Executive Director
Simon Kidston
Non--Executive Director
SPONSORED BY The Market Online